INZY (Inozyme Pharma Inc.): Time to Pay Attention?

In the latest session, Inozyme Pharma Inc. (NASDAQ: INZY) closed at $6.00 down -4.00% from its previous closing price of $6.25. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 519360 shares were traded. INZY stock price reached its highest trading level at $6.26 during the session, while it also had its lowest trading level at $5.76.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



For a deeper understanding of Inozyme Pharma Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.70 and its Current Ratio is at 10.70. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.

Upgrades & Downgrades

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 12 when Hopfner Robert Lorne bought 228,702 shares for $6.25 per share. The transaction valued at 1,429,388 led to the insider holds 3,661,518 shares of the business.

Hopfner Robert Lorne bought 219,230 shares of INZY for $1,420,610 on May 11. The Director now owns 3,432,816 shares after completing the transaction at $6.48 per share. On Mar 29, another insider, Hopfner Robert Lorne, who serves as the Director of the company, bought 344,592 shares for $4.54 each. As a result, the insider paid 1,563,724 and bolstered with 3,213,586 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INZY now has a Market Capitalization of 281.85M and an Enterprise Value of 160.76M.

Stock Price History:

Over the past 52 weeks, INZY has reached a high of $7.24, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is 5.40, while the 200-Day Moving Average is calculated to be 3.08.

Shares Statistics:

For the past three months, INZY has traded an average of 808.24K shares per day and 576.48k over the past ten days. A total of 43.72M shares are outstanding, with a floating share count of 39.82M. Insiders hold about 0.90% of the company’s shares, while institutions hold 86.70% stake in the company. Shares short for INZY as of May 14, 2023 were 606.32k with a Short Ratio of 0.61M, compared to 1.41M on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.38% and a Short% of Float of 1.39%.

Earnings Estimates

There are Incyte Corporation different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $15.66, with high estimates of $42.66 and low estimates of $6.00.

EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.